(Press-News.org) rain health in over 50s deteriorated more rapidly during the pandemic, even if they didn’t have COVID-19, according to major new research linking the pandemic to sustained cognitive decline.
Researchers looked at results from computerised brain function tests from more than 3,000 participants of the online PROTECT study, who were aged between 50 and 90 and based in the UK. The remote study, led by teams at the University of Exeter and the Institute of Psychiatry, Psychology & Neuroscience (IoPPN) at King’s College London, tested participants’ short term memory and ability to complete complex tasks.
Through analysing the results from this big dataset, researchers found that cognitive decline quickened significantly in the first year of the pandemic, when they found a 50 per cent change to the rate of decline across the study group. This figure was higher in those who already had mild cognitive decline before the pandemic, according to the research published in The Lancet Healthy Longevity.
This continued into the second year of the pandemic, suggesting an impact beyond the initial 12-month period of lockdowns. The researchers believe this sustained impact to be particularly relevant to ongoing public health and health policy.
The cognitive decline seems to have been exacerbated by a number of factors during the pandemic, including an increase in loneliness and depression, a decrease in exercise and higher alcohol consumption. Previous research has found that physical activity, treating existing depression, getting back into the community and reconnecting with people, are all important ways to reduce dementia risk and maintain brain health.
Anne Corbett, Professor of Dementia Research and PROTECT Study Lead at the University of Exeter, said: "Our findings suggest that lockdowns and other restrictions we experienced during the pandemic have had a real lasting impact on brain health in people aged 50 or over, even after the lockdowns ended. This raises the important question of whether people are at a potentially higher risk of cognitive decline which can lead to dementia. It is now more important than ever to make sure we are supporting people with early cognitive decline, especially because there are things they can do to reduce their risk of dementia later on. So if you are concerned about your memory the best thing to do is to make an appointment with your GP and get an assessment.
“Our findings also highlight the need for policy-makers to consider the wider health impacts of restrictions like lockdowns when planning for a future pandemic response."
Professor Dar Aarsland, Professor of Old Age Psychiatry at King’s IoPPN, said “This study adds to the knowledge of the long-standing health-consequences of COVID-19, in particular for vulnerable people such as older people with mild memory problems. We know a great deal of the risks for further decline, and now can add COVID-19 to this list. On the positive note, there is evidence that life-style changes and improved health management can positively influence mental functioning. The current study underlines the importance of careful monitoring of people at risk during major events such as the pandemic.”
The PROTECT study, a partnership with King’s College, London, is part of the National Institute for Health and Care Research Exeter Biomedical Research Centre’s world-leading Neurodegeneration theme research. The Centre, a partnership between The University of Exeter and the Royal Devon University Healthcare NHS Foundation Trust alongside other NHS organisations, has five core research themes aimed at translating scientific discoveries swiftly into benefits to patients.
The paper is entitled ‘Cognitive decline in older adults during and after the COVID-19 pandemic: a longitudinal analysis of the PROTECT UK study data’ and is published in The Lancet Healthy Longevity.
The PROTECT study is conducted entirely online and is open to new participants aged 40 and over. To find out more, visit: https://www.protectstudy.org.uk
END
Brain health in over 50s deteriorated more rapidly during the pandemic
Brain health in over 50s deteriorated more rapidly during the pandemic, even if they didn’t have COVID-19, according to major new research linking the pandemic to sustained cognitive decline
2023-11-02
ELSE PRESS RELEASES FROM THIS DATE:
Low Emission Zones improve air quality, health, and people’s well-being – new policy brief
2023-11-02
The introduction of London's Low Emission Zone (LEZ) in 2008 and subsequent Ultra-Low Emission Zone (ULEZ) from 2019 has significantly improved air quality, benefiting Londoners’ physical and mental health, according to new analysis from the Department of Economics at the University of Bath.
A new Institute for Policy Research (IPR) policy brief, presenting research from health economists at the University, indicates that the introduction of the LEZ helped to reduce particulate matter (PM10) in Greater London by 13% between 2008-13, compared to pre-LEZ levels (2003-07).
The ULEZ has had an even more substantial impact, ...
An MRI-equipped ambulance: A game-changer for stroke care?
2023-11-02
In the U.S., someone has a stroke every 40 seconds and dies from it every three minutes and 14 seconds, according to the Centers for Disease Control and Prevention. When it comes to stroke, experts echo the fact that time is brain. Faster treatment translates to better outcomes, and certain treatments, like the clot-busting drug tPA, have a strict time window for administration.
“The quicker that we can get the patient to treatment, the quicker we can have a good outcome,” said Dustin LeBlanc, M.D., director of Prehospital Medicine and associate chief medical officer for Emergency Management at the Medical University of South Carolina (MUSC). ...
Repurposed drug offers new potential for managing type 1 diabetes
2023-11-01
INDIANAPOLIS -- A recent study led by Indiana University School of Medicine in collaboration with the University of Chicago Medicine presents exciting future possibilities for the management of type 1 diabetes and the potential reduction of insulin dependency. The researchers’ findings, published in Cell Reports Medicine, suggest repurposing of the drug α-difluoromethylornithine (DFMO) may open doors to innovative therapies in the future.
Type 1 diabetes is a chronic condition wherein the body's immune system mistakenly ...
UCF hires Director of Development and Operations for Virtual Experience Research Accelerator (VERA)
2023-11-01
UCF Hires Director of Development and Operations for Virtual Experience Research Accelerator (VERA)
ORLANDO, Nov. 1, 2023 – Ali Haskins Lisle, Ph.D., has been named the Director of Development and Operations for the UCF-led Virtual Experience Research Accelerator (VERA).
VERA is a nearly $5 million U.S. National Science Foundation project to develop the first large-scale human-machine system for virtual reality human subjects research, with the goals of affording very large studies, very quickly, with populations that ...
Hebrew prayer book fills gap in Italian earthquake history
2023-11-01
The chance discovery of a note written in a 15th century Hebrew prayer book fills an important gap in the historical Italian earthquake record, offering a brief glimpse of a previously unknown earthquake affecting the Marche region in the central Apennines.
Paolo Galli, who found the note in the Apostolic Vatican Library while looking for contemporaneous accounts of another historic Italian earthquake, writes in Seismological Research Letters that the note “not only helps us partially fill a gap in the seismic history ...
UChicago chemists make breakthrough in drug discovery chemistry
2023-11-01
For years, if you asked the people working to create new pharmaceutical drugs what they wished for, at the top of their lists would be a way to easily replace a carbon atom with a nitrogen atom in a molecule.
But two studies from chemists at the University of Chicago, published in Science and Nature, offer two new methods to address this wish. The findings could make it easier to develop new drugs.
“This is the grand-challenge problem that I started my lab to try to solve,” said Mark Levin, ...
Docetaxel use associated with significant reduction in prostate cancer death in very poor prognostic group
2023-11-01
Men with high-grade prostate cancer and low prostate-specific antigen (PSA) levels have a poor prognosis. The question remains as to whether the chemotherapy drug docetaxel, which increases survival in metastatic prostate cancer, can improve the cure rate in these patients.
In a new study, investigators from Brigham and Women’s Hospital, a founding member of the Mass General Brigham healthcare system, a meta-analysis of five prospective randomized clinical trials (RCTs) found that adding docetaxel to standard-of-care (SOC) treatment was associated with a 70% reduction in death from prostate cancer-specific ...
Pet ownership may contribute to health care barriers for people with HIV
2023-11-01
People living with HIV may face hard choices when balancing their own health needs with caring for a pet, a study led by a University of Florida College of Public Health and Health Professions researcher finds.
For the study, which appears in the journal PLOS ONE, 36% of people with HIV who own pets reported delaying health care, not seeking it or said they expect to do so in the future. Financial and other resource concerns, including not having access to pet sitting or boarding services, are among the leading factors that may contribute to health care barriers among pet owners ...
Test detects co-infection by novel species of parasite in severe cases of visceral leishmaniasis
2023-11-01
In recent years, physicians and scientists in parts of Brazil where visceral leishmaniasis (VL) is endemic have seen rising numbers of cases of co-infection by Leishmania infantum and Crithidia, also a protozoan but hitherto believed to be a mosquito parasite that cannot infect humans or other mammals. Accurate diagnosis is hindered by a lack of simple specific tests (more at: https://agencia.fapesp.br/42072 and https://agencia.fapesp.br/31581).
To accelerate and facilitate detection of the pathogens involved, supporting appropriate decisions regarding treatment, researchers at the Federal University of São Carlos (UFSCar) have developed a PCR test ...
Dr. Zainab Mahmoud to receive the 2023 Dr. Nanette K. Wenger Research Goes Red® Award
2023-11-01
DALLAS, Nov. 1, 2023 – The American Heart Association will present the 2023 Dr. Nanette K. Wenger Research Goes Red® Award to Zainab Mahmoud, M.D., M.Sc., of Washington University School of Medicine in St. Louis. This award will be presented during the opening session of the Association’s Scientific Sessions 2023 on Saturday, Nov. 11. The meeting, to be held in Philadelphia, Saturday, Nov. 11 through Monday, Nov. 13, is a premier global exchange of the latest scientific advancements, ...
LAST 30 PRESS RELEASES:
High exposure to everyday chemicals linked to asthma risk in children
How can brands address growing consumer scepticism?
New paradigm of quantum information technology revealed through light-matter interaction!
MSU researchers find trees acclimate to changing temperatures
World's first visual grading system developed to combat microplastic fashion pollution
Teenage truancy rates rise in English-speaking countries
Cholesterol is not the only lipid involved in trans fat-driven cardiovascular disease
Study: How can low-dose ketamine, a ‘lifesaving’ drug for major depression, alleviate symptoms within hours? UB research reveals how
New nasal vaccine shows promise in curbing whooping cough spread
Smarter blood tests from MSU researchers deliver faster diagnoses, improved outcomes
Q&A: A new medical AI model can help spot systemic disease by looking at a range of image types
For low-risk pregnancies, planned home births just as safe as birth center births, study shows
Leaner large language models could enable efficient local use on phones and laptops
‘Map of Life’ team wins $2 million prize for innovative rainforest tracking
Rise in pancreatic cancer cases among young adults may be overdiagnosis
New study: Short-lived soda tax reinforces alternative presumptions on tax impacts on consumer behaviors
Fewer than 1 in 5 know the 988 suicide lifeline
Semaglutide eligibility across all current indications for US adults
Can podcasts create healthier habits?
Zerlasiran—A small-interfering RNA targeting lipoprotein(a)
Anti-obesity drugs, lifestyle interventions show cardiovascular benefits beyond weight loss
Oral muvalaplin for lowering of lipoprotein(a)
Revealing the hidden costs of what we eat
New therapies at Kennedy Krieger offer effective treatment for managing Tourette syndrome
American soil losing more nutrients for crops due to heavier rainstorms, study shows
With new imaging approach, ADA Forsyth scientists closely analyze microbial adhesive interactions
Global antibiotic consumption has increased by more than 21 percent since 2016
New study shows how social bonds help tool-using monkeys learn new skills
Modeling and analysis reveals technological, environmental challenges to increasing water recovery from desalination
Navy’s Airborne Scientific Development Squadron welcomes new commander
[Press-News.org] Brain health in over 50s deteriorated more rapidly during the pandemicBrain health in over 50s deteriorated more rapidly during the pandemic, even if they didn’t have COVID-19, according to major new research linking the pandemic to sustained cognitive decline